Amrize (NYSE:AMRZ) Stock Price Target Lowered at Truist Financial

Key Points

• Truist Financial lowered Amrize’s price target from $48 to $35 and maintained a “hold” rating, implying about 6% downside from the stock’s $37.23 opening price.
• Analyst sentiment has weakened overall: Amrize has an average “hold” rating and a consensus price target of $51.76, with recent downgrades from RBC, JPMorgan, and Bank of America.
• The company’s latest quarterly earnings missed estimates, reporting $0.88 in EPS versus the $0.92 consensus, while CEO Jan Jenisch and other insiders purchased shares totaling approximately $2.16 million over the past 90 days.

Amrize (NYSE:AMRZ - Get Free Report) had its price objective dropped by analysts at Truist Financial from $48.00 to $35.00 in a report released on Monday, Benzinga reports. The brokerage presently has a "hold" rating on the stock. Truist Financial's target price would suggest a potential downside of 5.98% from the stock's current price.

Other equities research analysts also recently issued reports about the stock. Royal Bank Of Canada downgraded shares of Amrize from a "sector perform" rating to an "underperform" rating and dropped their price target for the stock from $60.00 to $48.00 in a research note on Monday, August 10th. JPMorgan Chase & Co. downgraded Amrize from an "overweight" rating to a "neutral" rating and dropped their price objective for the company from $57.00 to $52.00 in a report on Wednesday, September 2nd. Sanford C. Bernstein reissued an "outperform" rating and issued a $60.00 target price on shares of Amrize in a research note on Monday, September 21st. Bank of America reaffirmed an "underperform" rating and issued a $40.00 price target (down from $50.00) on shares of Amrize in a research note on Wednesday, September 2nd. Finally, Deutsche Bank Aktiengesellschaft cut their price target on shares of Amrize from $64.00 to $56.00 and set a "buy" rating on the stock in a research report on Wednesday, September 23rd. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, eight have given a Hold rating and three have given a Sell rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $51.76.

Amrize Stock Performance

Shares of NYSE:AMRZ opened at $37.23 on Monday. Amrize has a fifty-two week low of $36.55 and a fifty-two week high of $65.94. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.10 and a quick ratio of 0.73. The business's fifty day moving average price is $43.64 and its two-hundred day moving average price is $50.07. The stock has a market capitalization of $20.59 billion, a price-to-earnings ratio of 17.16, a price-to-earnings-growth ratio of 1.31 and a beta of 0.20.

Amrize (NYSE:AMRZ - Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $0.88 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.92 by ($0.04). The firm had revenue of $3.49 billion for the quarter. Amrize had a return on equity of 10.22% and a net margin of 9.89%. As a group, analysts predict that Amrize will post 2.46 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Jan Jenisch bought 26,000 shares of the firm's stock in a transaction that occurred on Wednesday, September 2nd. The stock was acquired at an average cost of $42.47 per share, with a total value of $1,104,220.00. Following the completion of the purchase, the chief executive officer owned 1,767,000 shares of the company's stock, valued at $75,044,490. This represents a 1.49% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Stephen Clark bought 5,260 shares of the stock in a transaction that occurred on Tuesday, August 11th. The shares were purchased at an average price of $47.31 per share, for a total transaction of $248,850.60. Following the completion of the acquisition, the insider owned 10,637 shares of the company's stock, valued at $503,236.47. The trade was a 97.82% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased 48,983 shares of company stock valued at $2,158,755 in the last ninety days. 0.54% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of AMRZ. MCF Advisors LLC acquired a new stake in Amrize in the 4th quarter valued at about $27,000. Continuum Advisory LLC acquired a new position in Amrize during the second quarter worth approximately $62,000. NewEdge Advisors LLC increased its position in Amrize by 1,419.7% during the second quarter. NewEdge Advisors LLC now owns 2,082 shares of the company's stock worth $111,000 after buying an additional 1,945 shares during the last quarter. Oslo Pensjonsforsikring AS bought a new stake in Amrize in the first quarter valued at approximately $133,000. Finally, Caldwell Sutter Capital Inc. raised its stake in Amrize by 11.5% in the first quarter. Caldwell Sutter Capital Inc. now owns 2,675 shares of the company's stock valued at $150,000 after buying an additional 275 shares during the period.

Amrize Company Profile

Amrize Ltd. is a North American building solutions company that produces and supplies essential construction materials and related products. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, concrete products and roofing systems used in residential, commercial and infrastructure projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and other operating sites. Its products support a range of construction applications, including roads, bridges, buildings, homes and other major infrastructure.

Amrize was established as the result of the separation of Holcim's North American business and began operating as an independent, publicly traded company in 2025.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.